SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001213900-24-070241
Filing Date
2024-08-16
Accepted
2024-08-16 17:16:54
Documents
2
Period of Report
2024-08-16

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY INFORMATION STATEMENT ea0211467-pre14c_elevai.htm PRE 14C 183158
2 GRAPHIC image_001.jpg GRAPHIC 2731
  Complete submission text file 0001213900-24-070241.txt   188244
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 001-41875 | Film No.: 241217611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)